RMC No. 131-2024 — Publishing the full text of the October 14, 2024 letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) endorsing updates to the list of VAT-exempt products under Republic Act (R.A.) No. 10963 (TRAIN Law) and R.A. No. 11534 (CREATE Act) Digest | Full Text | Annex A

REPUBLIC OF THE PHILIPPINES

BUREAU OF INTERNAL REVENUE DEPARTMENT OF FINANCE

Bringing In Revenues for Nation-Building PILIDINAS BAGONG

REVENUE MEMORANDUM CIRCULAR NO...1 3 1 - 2 0 2 4

SUBJECT : Publishing the Full Text of the October 14, 2024 Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Endorsing No. 10963 (TRAIN Law) and R.A. No. 11534 (CREATE Act) Updates to the List of VAT-Exempt Products Under Republic Act (R.A.)

TO : All Internal Revenue Officers and Others Concerned

Under R.A. No. 11534 or the CREATE Act, particularly the following: concerned, attached is the October 14, 2024 letter (Annex "A") from Dr. Samuel A. Zacate, Director General of the FDA, for an update to the published List of VAT-Exempt Medicines For the information and guidance of all internal revenue officers, employees and others

1. Inclusion of certain medicines for cancer, diabetes, and mental illness; and

2. Correction and deletion of medicine for cancer.

As clarified under Q&A No. 1 of RMC No. 99-2021, the effectivity of the VAT exemption of the covered medicines and medical devices under the CREATE Act shall be on the date of publication by the FDA of the updates to the said list.

All concerned are hereby enjoined to be guided accordingly and give this Circular as wide a publicity as possible.

M

JR

DEC 03 2024 Kissioner of Internal Revenue

3

BiR National Office Bldg., Senator Miriam Defensor-Santiago Avenue, Diliman, Quezon City Trunkline: 8981-7000 : 8929-7676 Website: www.bir.gov.ph